Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT04830020
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18
* Diagnosis of COVID19 by validated SARS-CoV-2 antigen, RT-PCR, or other molecular diagnostic assay, using an appropriate sample such as NP, nasal, oropharyngeal \[OP\], or saliva) and no alternative explanation for current clinical condition.
* Respiratory failure requiring oxygen therapy
* Has symptoms consistent with COVID-19, and is in non-fibroproliferative stage of disease, as determined by investigator.
Exclusion Criteria:
* Respiratory arrest or the need for immediate intubation;
* Upper airway obstruction;
* Facial trauma;
* Inability to cooperate (e.g. agitation or dementia)
* Inability to give informed consent
* Participation in another study for COVID19 treatments
* Deterioration due to other reasons than progressive COVID19 pneumonia per clinical judgment, e.g. pulmonary thromboembolism, heart failure, renal failure etc.
* Palliative care or expectation that patient will not survive \> 72 hours post randomization per clinical judgment of the investigator.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04830020
Study Brief:
Protocol Section:
NCT04830020